UCSFʻs Dr. Thomas Hope on FDA-approved PSMA-targeted PET imaging drug for men with prostate cancer.

December 1, 2020. Dr. Thomas Hope, UCSF Helen Diller Family Comprehensive Cancer Center, discusses the significance of todayʻs FDA approval of Gallium 68 PSMA-11 (Ga 68 PSMA-11) - the first drug for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer.

[@ancanfoundation]

Congrats Dr. Hope - this is a gane changer!

[@oldman9154]

Lets find a cure. Thanks.

[@luketoni2902]

Dear Dr. Hope, how can I sign up to have the PSMA targeted pet scan performed on me? Where do I start? Thank you

[@UCSFCancer]

Thanks for your question. See the section "How to get a PSMA PET Scan?" on this page for information on scheduling a PSMA Pet Scan radiology.ucsf.edu/psma-pet-scan-for-prostate-cancer